Please Wait.....
Report
India Wound Care Market Assessment, By Product [Advanced Wound Dressings, Surgical Wound Care, Traditional Wound Care, Wound Therapy Devices], By Applications [Chronic Wounds, Acute Wounds], By End-user [Hospitals, Outpatient Facilities, Home care, Research and Manufacturing], By Mode of Purchase [Prescribed, Non-Prescribed], By Distribution Channel [Institutional Sales, Retail Sales], By Region, Opportunities and Forecast, FY2017-FY2031F
Market Report I 2024-04-19 I 128 Pages I Market Xcel - Markets and Data
India wound care market size was valued at USD 1.81 billion in FY2023, and is expected to reach USD 2.75 billion in FY2031, with a CAGR of 5.39% for the forecast period between FY2024 and FY2031. Anticipated factors contributing to the growth of India's wound care market include the rising occurrences of chronic wounds, ulcers, and diabetic ulcers, growing prevalence of diabetes, particularly as a leading cause of diabetic foot ulcers in India, and the introduction of advanced technological products. The wound care market in India has witnessed significant growth and transformation in recent years, reflecting the country's expanding healthcare infrastructure and increasing awareness of wound management.
The market encompasses a wide range of products and services aimed at treating wounds, injuries, and surgical procedures. Technological advancements in wound care products, including dressings, grafts, and negative pressure wound therapy systems, have improved treatment outcomes and patient comfort. These innovations have garnered a significant share of the market. The Indian government is taking steps to improve wound care services in the country.
Increasing Prevalence of Diabetes and Injuries
The Indian population is contributing to an increase in the number of diabetic patients, as India is now considered as the "Diabetes Capital of the World." It can have a significant effect because diabetic patients have slower healing processes. More than 100 million people in India are living with diabetes and 136 million with pre-diabetes. As a result, the increasing number of diabetes patients, who are more susceptible to developing ulcers, are expected to drive market growth. According to data from Ministry of Road Transport and Highways in 2022, more than 460,000 road accidents took place in India, which led to 168,491 deaths and 443,366 injuries.
Introduction of Advanced Technologies
The Indian wound care market has witnessed a significant transformation with the introduction of advanced technological equipment. Innovations in wound management, such as smart dressings, antimicrobial gels, and telemedicine solutions, have revolutionized patient care. These innovative products have enhanced treatment efficacy and improved patient outcomes by facilitating remote monitoring and personalized care. The convergence of technology and healthcare in the wound care sector is rapidly shaping the landscape, offering more efficient and cost-effective solutions for addressing various types of wounds, from chronic ulcers to post-surgical incisions, ultimately benefiting both patients and healthcare providers in India. On May 11, 2023, the National Chemical Laboratory in Pune approved the technology of manufacturing bacterial nanocellulose for wound care and cosmetic applications to RapidCure Healthcare Pvt. Ltd. The nanocellulose produced exhibit exceptional purity levels and distinctive micromorphology, making it suitable for a range of commercially significant application.
On December 13, 2022, MediWound Ltd., a biopharmaceutical company, revealed the market approval for NexoBrid in India. NexoBrid, a biologically applied substance, is designed for topical use and, after four hours of treatment it enzymatically removes nonviable burn tissue from patients with deep partial and full-thickness thermal burns without causing harm to viable tissue.
Strategic Collaborations Among Leading Industry Players
In India wound care market, strategic collaborations among industry leaders are driving innovation and expanding access to advanced healthcare solutions. For instance, Mediwound, a biopharmaceutical firm, revealed on December 13, 2022, its partnership with Bharat Serums and Vaccines Limited, which specializes in developing blood components and therapeutic antibody products for infectious and non-infectious ailments. The collaboration pertains to the distribution of NexoBrid, a topically administered biological product in India to manage severe burns. Bharat Serums and Vaccines Limited is anticipated to commence the commercialization of NexoBrid in the Indian market. These collaborations are enhancing research and development efforts, enabling the introduction of more effective wound management products, and ultimately improving patient outcomes. The synergy between healthcare institutions and wound care product manufacturers is driving progress in this critical sector is addressing the growing healthcare needs of India's population.
Increasing Product Launches
While product launches make a significant impression on the India wound care market, the advancements and improvements of these products carry an even more substantial influence. For instance, in September 2021, a U.S. headquartered company, Human Bioscience, launched two products, namely "Skin Temp" and "Medifil," in the Indian market. In July 2023, Smith & Nephew introduced the REGENTEN Bio-inductive implant in the Indian market. The implant is specifically engineered to aid in wound care by promoting the body's natural healing processes and encouraging the development of tendon tissue. In February 2021, Axio Biosolutions, based in Karnataka, India, obtained CE Certification for their advanced wound-care product, MaxioCel.
Impact of COVID-19
The spread of COVID-19 pandemic led to a significant disruption in healthcare services, including the treatment of patients with wounds. In response to urgent needs, there was a shift in the approach to wound care, which is typically considered a vital medical service. During this period, the primary goals of wound care shifted from primarily focusing on complete wound healing, which involves the use of antibiotics, appropriate dressings, and proper management that necessitates regular hospital visits, to a more proactive approach aimed at preventing severe wound complications, reducing the need for hospitalization and surgery when possible.
Key Players Landscape and Outlook
India's status as a developing nation is capable of manufacturing wound care devices, it has led to a rising need for wound care devices, subsequently contributing to the expansion of the wound care market. As a result, the market has become increasingly attractive, enticing global players to establish their presence in India.
On July 2023, Smith & Nephew introduced the REGENTEN Bio-inductive implant to the Indian market. This implant is specifically engineered to aid in wound care by promoting the body's natural healing processes and encouraging the development of tendon tissue.
1. Research Methodology
2. Project Scope & Definitions
3. Impact of COVID-19 on India Wound Care Market
4. Executive Summary
5. India Wound Care Market Outlook, FY2017-FY2031F
5.1. Market Size & Forecast
5.1.1. By Value
5.1.2. By Volume
5.2. By Product
5.2.1. Advanced Wound Dressings
5.2.1.1. Foam Dressings
5.2.1.2. Hydrocolloid Dressings
5.2.1.3. Film Dressings
5.2.1.4. Alginate Dressings
5.2.1.5. Hydrogel Dressings
5.2.1.6. Collagen Dressings
5.2.1.7. Others
5.2.2. Surgical Wound Care
5.2.2.1. Sutures & Staples
5.2.2.2. Tissue Adhesive and Sealants
5.2.2.3. Anti-Infective Dressing
5.2.3. Traditional Wound Care
5.2.3.1. Medical Tapes
5.2.3.2. Cotton
5.2.3.3. Bandages
5.2.3.4. Gauzes
5.2.3.5. Sponges
5.2.3.6. Cleansing Agents
5.2.4. Wound Therapy Devices
5.2.4.1. Negative Pressure Wound Therapy
5.2.4.2. Oxygen And Hyperbaric Oxygen Equipment
5.2.4.3. Electric Stimulation Devices
5.2.4.4. Pressure Relief Devices
5.2.4.5. Others
5.3. By Applications
5.3.1. Chronic Wounds
5.3.1.1. Diabetic Foot Ulcers
5.3.1.2. Pressure Ulcers
5.3.1.3. Venous Leg Ulcers
5.3.1.4. Other
5.3.2. Acute Wounds
5.3.2.1. Surgical & Traumatic Wounds
5.3.2.2. Burns
5.4. By End-user
5.4.1. Hospitals
5.4.2. Outpatient Facilities
5.4.3. Home Care
5.4.4. Research and Manufacturing
5.5. Mode of Purchase
5.5.1. Prescribed
5.5.2. Non-prescribed (OTC)
5.6. Distribution Channel
5.6.1. Institutional Sales
5.6.2. Retail Sales
5.7. By Region
5.7.1. North
5.7.2. South
5.7.3. East
5.7.4. West
5.7.5. Central
5.8. By Company Market Share (%), FY2023
6. Market Mapping, FY2023
6.1. By Product
6.2. By Application
6.3. By End-user
6.4. By Mode of Purchase
6.5. Distribution Channel
6.6. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis - Volume and Value
7.3. Supply/Value Chain Analysis
7.4. PESTEL Analysis
7.4.1. Political Factors
7.4.2. Economic System
7.4.3. Social Implications
7.4.4. Technological Advancements
7.4.5. Environmental Impacts
7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
7.5.1. Supplier Power
7.5.2. Buyer Power
7.5.3. Substitution Threat
7.5.4. Threat from New Entrant
7.5.5. Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges, Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Smith & Nephew
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. 3M Company
13.3. B. Braun Melsungen AG
13.4. Cardinal Health Inc.
13.5. Coloplast A/S
13.6. ConvaTec Group PLC
13.7. Integra Lifesciences
13.8. Medtronic PLC
13.9. Molnlycke Health Care
13.10. Paul Hartmann AG
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security